The Latest Cardiac and Vascular News
Revenue exceeds guidance, with known supply chain challenges impacting results; notable strength in Pacing, Cardiac Surgery, Core Spine in the U.S., and Diabetes in Europe DUBLIN, Aug. 23, 2022 /PRNewswire/ — Medtronic plc (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2023, which ended July 29, 2022. Key Highlights GAAP […]
DUBLIN, Aug. 18, 2022 /PRNewswire/ — The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 18, 2022, approved the fiscal year 2023 second quarter cash dividend of $0.68 per ordinary share, representing an 8% increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in May […]
Funding Will Accelerate Commercialization of the ECGenius™ System and Expand Development of Analytic Modules COPENHAGEN, Denmark, Aug. 17, 2022 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions designed to enhance clinical decision making in the EP lab, today announced the company has secured $7.2 million in funding from existing investors. The financing […]
– Katrin Rupalla, Ph.D., appointed Chair of Ambrx’s Board of Directors – – Ambrx to conduct strategic pipeline review with focus on commercial opportunity and cash runway extension – – Dr. Tian will continue to be available to Ambrx in an advisory capacity – SAN DIEGO–(BUSINESS WIRE)–Ambrx Biopharma Inc., or […]
MOUNTAIN VIEW, Calif., Aug. 16, 2022 /PRNewswire/ — AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced its Series F Financing led by GE Healthcare. Also joining the round are NGK-NTK (through a CVC partnership with Pegasus Tech Ventures) and existing investors including Khosla Ventures, Bold Capital Partners, Qualcomm Ventures, […]
NEWTON, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious, rare and life-threatening diseases with significant unmet medical needs, today reported financial results for the second quarter ended June 30, 2022, and provided […]
SANUWAVE Health, Inc. today announced the appointment of Dr. Toni Rinow as CFO Eden Prairie, MN, Aug. 16, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, today announced the appointment of Dr. Toni Rinow, MBA as Chief Financial Officer (CFO). […]
Westport, CT, Aug. 16, 2022 (GLOBE NEWSWIRE) — Company sees increase in medical centers entering into 60-day evaluation agreements Existing customers seeing positive results from PURE EP™ System expected to increase number of units purchased BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company advancing electrophysiology workflow […]
Eden Prairie, MN, Aug. 15, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, reported financial results for their second quarter ending June 30, 2022, with the SEC on Friday, August 12, 2022. The Company will host a live conference call […]
WALTHAM, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, baxdrostat, for the treatment of hypertension and other cardio-renal diseases, today announced the closing of its previously announced upsized underwritten public offering consisting of an […]
